Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND) is blazing a trail in an emerging sector of pharmaceuticals: psychedelics. Thanks to a series of milestones reached, patents earned, and valuable partnerships, the company’s lead candidate, MEAI, may soon become the first-to-market psychedelic-based treatment targeting Alcohol Use Disorder (AUD). As an alcohol-substitute product, MEAI positions Clearmind to […]
Tag: Personal Finance
AppTech Payments Corp Shares Consolidate After Q4 Surge; Imminent Commerse™ Platform Launch Keeps Stock In Play ($APCX)
AppTech Payments Corp. (NASDAQ: APCX) stock saw some profit-taking. But based on the past two days of trading, the bullish momentum is still a force to reckon with. Last Thursday, APCX stock soared about 18% despite a considerable selloff in the broader markets. On Friday, APCX shares held gains, trading within a tight range and […]
AppTech Payments Corp Stock Bullish Ahead Of Commerse™ Platform Launch ($APCX)
AppTech Payments Corp. (NASDAQ: APCX) stock may be consolidating, but the Q4 rally from a technical basis remains intact. On Monday, APCX shares touched $1.10, a 61% increase from its initial standing in Q4 and an impressive 81% over the start of Q2. While shares may have pulled back yesterday, volume remains higher than average […]
KWIK’s Integration With Shopify Exposes A Valuation Disconnect Too Significant To Ignore ($KWIK)
KwikClick Inc. (OTCQB: KWIK) announced yesterday morning that it’s in the final stages of integrating its technology into the world’s largest E-commerce platform- Shopify. With that being the case, and with KWIK noting that the Shopify (NASDAQ: SHOP) deal will likely be followed with ones from Woo Commerce and Magento, it’s surprising that KWIK stock […]
Avalon GloboCare Shares Higher; Partnerships And Planned Acquisition Fuel Investor Interest ($ALBT)
Thinly traded Avalon GloboCare (NASDAQ: ALBT) stock is worthy of consideration, and savvy investors appear to be doing just that. In fact, shares moved more than 5% higher last week, touching $0.38 on higher-than-normal volume. By the way, calling ALBT shares “thinly traded” doesn’t imply that they are entirely under the radar. They certainly aren’t, […]
Actinium Pharmaceuticals’ Shares Stay Bullish Ahead Of Expected Topline Phase 3 Data Release In Q4 ($ATNM)
The bullish sentiment pushing Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) shares higher isn’t slowing. The stock held close to its monthly highs despite bearish market conditions weighing heavy on smallcap biotechs. Since the start of Q4, ATNM shares are higher by over 52% at press time, reaching $11.30 on Friday on higher than average volume. Perhaps […]
A Legendary Writer and Marketing Expert that has made Positive Contributions to the Knowledge about Autism
Jacson Marçal Pereira de Jesus One of the greatest discoveries in life is the discovery of a legend who impacts positively in the life of others, and such is Jacson Marçal. Jacson Marçal is a talented writer, autistic savant, and activist with diverse interests in Marketing, Technology, Mechanics and Medicine. He is an outstanding individual […]
Finance Valley Group Just Launched A New Website With A Complete Redesign And Added Features
Finance Valley Group has just launched a new and improved website – www.financevalley.com.au. Completely redesigned with a fresh, modern look, the site features easier access to Finance Valley news and relevant financial industry information. The new website also has a new navigation design to better organize content into sections on Different Loan Products, Areas the […]
Kaival Brands Expertly Navigates ENDS Market Restrictions; Looks to Capitalize on Now-Sparse Competitive Landscape (NASDAQ: KAVL)
There’s much to support the bullish position on Kaival Brands International (NASDAQ: KAVL). Take last June for instance, in which tobacco industry giant Philip Morris (NYSE: PM) signed a deal with KAVL’s wholly owned subsidiary, Kaival Brands International, LLC (“KBI”) for the development and distribution of electronic nicotine delivery system (ENDS) products in markets outside […]
Actinium Pharmaceuticals’ Shares Rally Ahead Of Topline Phase 3 Data Release; Update Expected By Year’s End ($ATNM)
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) stock is doing something most of its peers aren’t: rallying. In fact, since the start of Q4, ATNM shares are currently 48% higher than where they started. Keep in mind that the move is also coming at a time when broader markets, especially biotech, are again weakening. But when markets […]